Core Viewpoint - The article emphasizes the acceleration of innovation in China's cosmetic raw materials through regulatory reforms, particularly the "immediate reporting and review" system, which aims to enhance the industry's competitiveness on a global scale [2][6][12]. Regulatory Reforms - The National Medical Products Administration (NMPA) has introduced the "immediate reporting and review" system for new cosmetic raw materials, significantly shortening the approval process and encouraging innovation [6][12]. - A draft opinion on deepening cosmetic regulatory reforms has been prepared, indicating a shift towards a more systematic and high-quality regulatory framework [4][8]. - The NMPA is focusing on high-value innovative raw materials, providing personalized support to encourage genuine innovation [7][12]. Industry Growth - The cosmetic market in China reached a total transaction value of 107.38 billion yuan in 2024, with online sales accounting for 55.2% of the market share among the top 100 brands [8]. - As of August 20, 2025, there are 6,093 cosmetic production enterprises and over 2.24 million registered and filed cosmetic products, indicating rapid industry expansion [9]. Innovation and Market Dynamics - The NMPA's reforms are expected to lower innovation costs and time, allowing companies to respond more quickly to market demands and convert innovations into competitive advantages [12][14]. - The transition from a regulatory ordinance to a legal framework signifies an elevation of the cosmetic industry's status within the national economy [15]. Collaborative Governance - The NMPA aims to establish a governance framework that includes corporate responsibility, government regulation, industry self-discipline, and public participation to foster a healthy innovation ecosystem [11]. - The China Fragrance and Cosmetic Industry Association plays a crucial role in this governance structure, contributing to safety assessments and technological advancements in the industry [11].

Group 1 - The core viewpoint is that international raw material giants continue to dominate the high-end cosmetics market in China, while domestic companies are primarily focused on the mid-to-low end [1] - The registration and filing of new cosmetic raw materials in China will accelerate, with a new "immediate reporting and review" policy being implemented by the National Medical Products Administration (NMPA) [2] - As of June 30, 2025, a total of 272 new raw materials are expected to be registered and filed, with 262 of these being added after May 1, 2021, representing a 26-fold increase compared to the previous decade [2] Group 2 - The total transaction value of China's cosmetics market is projected to reach 1,073.822 billion yuan in 2024, reflecting a year-on-year growth of 2.8% [2] - The self-sufficiency rate for ordinary raw materials is approximately 60%, while the dependence on imports for high-end active ingredients, specialty oils, and functional monomers exceeds 70% [2] - The NMPA emphasizes the importance of raw material innovation as a cornerstone for the high-quality development of the cosmetics industry, indicating that domestic companies need to enhance their R&D investment and capabilities [3]

Core Viewpoint - The National Medical Products Administration (NMPA) reports a steady increase in the registration and filing of new cosmetic raw materials in China, with a total of 272 new materials expected by June 2025 [1] Group 1: Regulatory Changes - Since the implementation of the Cosmetic Supervision and Administration Regulations in 2021, significant adjustments have been made to the management of new cosmetic raw materials in China [1] - New raw materials are categorized based on their risk levels, with higher-risk materials requiring registration and others subject to filing management [1] Group 2: Support for Innovation - The NMPA is actively supporting innovation in cosmetic raw materials by optimizing the registration and filing processes [1] - There is an emphasis on enhancing the internal motivation for innovation among companies while ensuring quality and safety standards are maintained [1]